Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

New Delhi [India], May 30: Gujarat-based Aristo Bio-Tech and Lifescience Ltd, a fast-growing company in the agrochemical and biotechnology space, has reported a stellar financial performance for the fourth quarter and full financial year ended March 31, 2025 (FY25). The company posted a strong turnaround in profitability, with significant growth in revenue. Due to expansion and increased capital expenditure, depreciation has risen by Rs. 1 crore compared to last year, resulting in a lower visible profit.

Key Highlights: (in crores)